Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cardiac cell reprogramming with myocardin and ASCL1

Cardiac cell reprogramming with myocardin and ASCL1

US Patent 11913012 · Granted Feb 27, 2024

Estimated economic value: $10,453,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene therapy vectors for treating heart disease2025
Question analysis method, device, knowledge base question answering system and e2025
Method, apparatus, device and storage medium for training model2024
Cardiac cell reprogramming with myocardin and ASCL12024
Cardiac cell reprogramming with myocardin and ASCL12024
Optimized expression cassettes for gene therapy2024
Gene therapy vectors for treating heart disease2023
Method and apparatus for processing sematic description of text entity, and stor2023
Gene therapy vectors for treating heart disease2022
Method, apparatus, computer device and storage medium for verifying community qu2022
Method, apparatus, electronic device and computer readable medium for obtaining 2022
Query processing method, apparatus, server and storage medium2022